PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
Retrieved on:
Thursday, October 13, 2022
Biotechnology, Pharmaceutical, Health, Medical Devices, LinkedIn, Reproductive health, Caregiver, Noguchi, Disease, Sickle cell disease, Government, Informatics, Diagnosis, SCD, Science, YouTube, ESG, Medical research, Patient, Twitter, Instagram, PerkinElmer, Noguchi Memorial Institute for Medical Research, Automation, University, Decision-making, Company, University of Ghana, Safety, Food, Hydroxycarbamide, Ghana Health Service, Center, Fort Irwin National Training Center, Pharmaceutical industry, Facebook
The PerkinElmer-provided MigeleTM Gel Electrophoresis Systems will support Ghanas need for reliable, fast, and cost-efficient SCD screening.
Key Points:
- The PerkinElmer-provided MigeleTM Gel Electrophoresis Systems will support Ghanas need for reliable, fast, and cost-efficient SCD screening.
- With the governments desire to enact a country-wide screening program, the PerkinElmer solutions flexible and scalable design can meet growing high-capacity requirements as screening coverage and sample volumes increase.
- We would like to congratulate Ghana Health Services and the Sickle Cell Foundation for the milestones gained so far, in advancing the diagnosis and care of patients with the disease in the country.
- We hope that this donation will facilitate development of Ghanas SCD screening program and will therefore improve the lives of children in the region.